$39.4 Million is the total value of PIPER SANDLER & CO.'s 29 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 2200.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | Buy | SPDR S&P 500 ETF TRput | $10,194,000 | +33.0% | 50,000 | +25.0% | 25.87% | +215.7% |
| XLE | New | SELECT SECTOR SPDR TRput | $4,222,000 | – | 70,000 | +100.0% | 10.71% | – |
| New | NEWMONT MINING CORPnote 1.625% 7/1 | $1,183,000 | – | 1,206,000 | +100.0% | 3.00% | – | |
| New | ARES CAP CORPnote 5.750% 2/0 | $1,004,000 | – | 1,005,000 | +100.0% | 2.55% | – | |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDadr | $759,000 | – | 11,559 | +100.0% | 1.93% | – |
| New | SPECTRANETICS CORPmtnf 2.625% 6/0 | $754,000 | – | 1,000,000 | +100.0% | 1.91% | – | |
| New | ARES CAP CORPnote 5.125% 6/0 | $499,000 | – | 500,000 | +100.0% | 1.27% | – | |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $481,000 | – | 3,825 | +100.0% | 1.22% | – |
| VRX | New | VALEANT PHARMACEUTICALS INTL | $201,000 | – | 1,976 | +100.0% | 0.51% | – |
| THC | New | TENET HEALTHCARE CORP | $180,000 | – | 5,929 | +100.0% | 0.46% | – |
| LULU | New | LULULEMON ATHLETICA INC | $176,000 | – | 3,353 | +100.0% | 0.45% | – |
| BLUE | New | BLUEBIRD BIO INC | $145,000 | – | 2,256 | +100.0% | 0.37% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $145,000 | – | 1,385 | +100.0% | 0.37% | – |
| New | APOLLO INVT CORPnote 5.750% 1/1 | $125,000 | – | 125,000 | +100.0% | 0.32% | – | |
| ADHD | New | ALCOBRA LTD | $73,000 | – | 11,641 | +100.0% | 0.18% | – |
| RLYP | New | RELYPSA INC | $48,000 | – | 1,702 | +100.0% | 0.12% | – |
| LDRH | New | LDR HLDG CORP | $30,000 | – | 1,199 | +100.0% | 0.08% | – |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $23,000 | – | 700 | +100.0% | 0.06% | – |
| INCY | New | INCYTE CORP | $22,000 | – | 201 | +100.0% | 0.06% | – |
| OREX | New | OREXIGEN THERAPEUTICS INC | $17,000 | – | 9,809 | +100.0% | 0.04% | – |
| SGNT | New | SAGENT PHARMACEUTICALS INC | $3,000 | – | 185 | +100.0% | 0.01% | – |
| EARS | New | AURIS MED HLDG AG | $0 | – | 84 | +100.0% | 0.00% | – |
| CMRX | New | CHIMERIX INC | $0 | – | 22 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SHATTUCK LABS INC | 15 | Q2 2024 | 4.1% |
| U S WELL SVCS INC | 12 | Q4 2021 | 3.7% |
| SPDR S&P 500 ETF TR | 11 | Q2 2016 | 81.8% |
| GENCORP INC | 10 | Q3 2016 | 32.4% |
| OPPFI INC | 10 | Q1 2024 | 0.6% |
| OPPFI INC | 10 | Q1 2024 | 0.1% |
| WELLPOINT INC | 9 | Q4 2022 | 25.5% |
| INCONTACT INC | 9 | Q1 2016 | 0.6% |
| CARTESIAN GROWTH CORP II | 9 | Q2 2024 | 0.1% |
| NICE SYS INC | 8 | Q4 2023 | 27.6% |
View PIPER SANDLER & CO.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| MA-I/A | 2024-09-25 |
| MA-I | 2024-09-25 |
| MA-I/A | 2024-09-20 |
| MA-I | 2024-09-10 |
| MA/A | 2024-08-19 |
| 13F-HR | 2024-08-08 |
| MA-I/A | 2024-08-07 |
| MA-I | 2024-08-02 |
| MA-I/A | 2024-07-24 |
| MA-I/A | 2024-07-24 |
View PIPER SANDLER & CO.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.